Benitec Biopharma Inc.

NASDAQ:BNTC

Biotechnology

Healthcare
$8.27 +3.05%

+$0.36 today

Market cap
$288.53M
Beta
0.28
P/E (TTM)
-12.3
EPS (TTM)
-$0.99
52W Low $9.85High $16.76

Volume 0.13M

Average 0.11M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$41.77M

FY 2025 · Annual

Net Income

-$37.92M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue59K73K75K00
Cost of Revenue123K9K0343K0
Gross Profit(64K)64K75K(343K)(396K)
Gross Margin-108.5%87.7%100.0%——
Research & Development7.02M11.27M12.77M15.61M18.33M
Selling, General & Admin6.51M6.65M6.38M6.99M23.43M
Operating Expenses13.53M17.92M19.16M22.49M41.77M
Depreciation & Amortization424K392K381K343K396K
EBITDA(13.45M)(17.78M)(18.7M)(22.15M)(41.37M)
EBITDA Margin-22800.0%-24361.6%-24933.3%——
Operating Income(13.6M)(17.85M)(19.08M)(22.49M)(41.77M)
Operating Margin-23044.1%-24457.5%-25441.3%——
Interest Income000904K0
Interest Expense6K32K33K00
Other Income / Expenses(286K)(354K)(481K)739K3.85M
Income Before Tax(13.88M)(18.21M)(19.56M)(21.75M)(37.92M)
Pre-Tax Margin-23528.8%-24942.5%-26082.7%——
Income Tax Expense00000
Net Income(13.88M)(18.21M)(19.56M)(21.75M)(37.92M)
Net Margin-23528.8%-24942.5%-26082.7%——
EPS (Basic)(27.27)(19.31)(14.12)(2.68)(1.05)
EPS (Diluted)(27.27)(19.31)(14.12)(2.68)(1.05)
Weighted Avg Shares1.01M1.92M1.39M10.26M36.21M
Weighted Avg Shares (Diluted)1.01M1.92M1.39M10.28M36.21M

BNTC Earnings Waterfall · TTM

NASDAQ:BNTC · Revenue to Net Income

Key Ratios

EPS$-1.11
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-11.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$48.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.11, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 13, 2026
8-KCurrent reportOct 28, 2026
DEFA14ADEFA14A filingOct 20, 2026
DEF 14ADEF 14A filingOct 20, 2026

How much revenue does BNTC generate?

Benitec Biopharma Inc. (BNTC) reported $0.00 of revenue in fiscal 2025.

Is BNTC profitable?

Benitec Biopharma Inc. (BNTC) reported -$37.92M of net income.